AB
IMNM icon

Amalgamated Bank’s Immunome IMNM Stock Holding History

Amalgamated Bank’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,943
Closed -$63K – 2202
2025
Q4 		$63K Buy
2,943
+499
+20% +$8.76K ﹤0.01% 1779
2025
Q3 		$29K Hold
2,444
– – ﹤0.01% 1995
2025
Q2 		$23K Hold
2,444
– – ﹤0.01% 2061
2025
Q1 		$16K Buy
2,444
+666
+37% +$6.39K ﹤0.01% 2154
2024
Q4 		$19K Hold
1,778
– – ﹤0.01% 2134
2024
Q3 		$26K Hold
1,778
– – ﹤0.01% 2034
2024
Q2 		$22K Buy
+1,778
New +$27.8K ﹤0.01% 2082

Other funds holding IMNM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return

Amalgamated Bank's IMNM Position: Q1 2026 in Review

Amalgamated Bank sold out of Immunome (IMNM) in Q1 2026, closing a stake of 2,943 shares — an estimated $63K sold.

Amalgamated Bank first reported a position in IMNM in Q2 2024 and held it in 7 quarters. The position peaked at $63K in Q4 2025. 201 funds tracked by Wall St. Rank hold IMNM as of Q1 2026.

  • Amalgamated Bank reported no remaining Immunome position as of Q1 2026 after selling out during the quarter.
  • Amalgamated Bank sold 2,943 Immunome shares in Q1 2026, an estimated $63K.
  • Amalgamated Bank first reported a position in Immunome in Q2 2024 and held it in 7 quarters.
  • Amalgamated Bank's Immunome position peaked at $63K in Q4 2025.
  • 201 funds tracked by Wall St. Rank held Immunome as of Q1 2026.

Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.